Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna, Merck cancer combo cuts melanoma spread risk at five years
05:03pm, Thursday, 21'st May 2026
Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body by 59% after five years of follow-up, data from a mid-stage trial showe
US FDA to hold expert committee meeting to review Moderna's flu vaccine
11:26am, Thursday, 21'st May 2026
The U.S. FDA said on Thursday it would hold a meeting of outside experts next month to review Moderna's experimental flu shot.
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
09:36am, Thursday, 21'st May 2026
Moderna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement.
Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
12:20pm, Tuesday, 19'th May 2026
Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
01:15pm, Wednesday, 13'th May 2026
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.
Moderna Recognized by TIME as One of the World's Most Impactful Companies
05:00pm, Tuesday, 12'th May 2026
CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies.
Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
04:50pm, Tuesday, 12'th May 2026
Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Moderna's AI Could Get a Hantavirus Vaccine Here Faster
01:25pm, Tuesday, 12'th May 2026
Drug development has always been a slow business. A single medicine can take 10 to 15 years and cost billions before it reaches a patient.
Hantavirus outbreak: these 3 stocks are poised to rip higher
11:44pm, Monday, 11'th May 2026
The World Health Organization's recent report of a Hantavirus cluster aboard a cruise ship departing Argentina has refocused global market attention on zoonotic respiratory pathogens. Three confirmed
Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.
08:19pm, Monday, 11'th May 2026
Moderna's stock is rallying on hopes it could develop a hantavirus vaccine.
Here's how much Moderna's stock has rallied off renewed focus on hantavirus research
01:17pm, Monday, 11'th May 2026
The public is growing increasingly concerned about the possibility that a hantavirus outbreak on a cruise could spark a new pandemic.
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone?
11:48am, Monday, 11'th May 2026
Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.
Moderna shares extend gains as hantavirus vaccine work draws attention
11:43am, Monday, 11'th May 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares continued to extend recent gains on Monday as investors welcomed reports that the company is researching a hantavirus vaccine and advancing early-stage work
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
10:53am, Monday, 11'th May 2026
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35.
Moderna stock soars as hantavirus fears spark outbreak trade
10:44am, Monday, 11'th May 2026
Moderna shares surged on Monday as investors rushed into vaccine and biotech stocks following reports of a hantavirus outbreak linked to a cruise ship, despite health authorities maintaining that the
